Barclays PLC (NYSE:BCS) Surpasses Earnings Expectations

Posted Feb 18 by John Deo

Barclays PLC (NYSE:BCS) reported earnings per share of $0.44, significantly beating the estimated $0.19. The

Source: Two Blokes Trading

Oatly Group AB's Strategic Reverse Stock Split and Business Transformation

Posted Feb 18 by John Deo

Oatly Group AB (NASDAQ:OTLY) executed a reverse stock split at a 20-for-1 ratio, aiming to increase its stock

Source: Two Blokes Trading

Garmin Ltd. (GRMN) Quarterly Earnings Preview

Posted Feb 18 by John Deo

Garmin Ltd. (NYSE:GRMN) is expected to report an EPS of $1.90 and revenue of approximately $1.7 billion for t

Source: Two Blokes Trading

Ideaya Biosciences, Inc. (NASDAQ:IDYA) Faces Financial Challenges Despite Revenue Growth

Posted Feb 18 by John Deo

Ideaya Biosciences reported an earnings per share (EPS) of -$1.49, significantly below the estimated EPS, ind

Source: Two Blokes Trading

Innovative Industrial Properties: A Strong Dividend Growth Stock

Posted Feb 18 by John Deo

Earnings Expectations: Analysts predict an EPS of $2.22 and revenue of $76.2 million for the upcoming quarter

Source: Two Blokes Trading

STAAR Surgical Company (NASDAQ:STAA) Earnings Preview and Financial Health Analysis

Posted Feb 18 by John Deo

STAAR Surgical Company (NASDAQ:STAA) is set to release its quarterly earnings with an estimated EPS of $0.02

Source: Two Blokes Trading

The Cheesecake Factory Incorporated (NASDAQ:CAKE) Anticipates Quarterly Earnings Release

Posted Feb 18 by John Deo

Wall Street analysts expect earnings per share (EPS) of $0.91 and revenue of approximately $912.7 million for

Source: Two Blokes Trading

BHP Group Ltd (NYSE:BHP) Faces Challenges but Remains Optimistic

Posted Feb 18 by John Deo

Earnings per share of $1.72 fell short of the estimated $1.99, while revenue slightly surpassed expectations

Source: Two Blokes Trading

Nexa Resources S.A. (NYSE:NEXA) Quarterly Earnings Preview

Posted Feb 18 by John Deo

Nexa Resources S.A. (NYSE:NEXA) is a prominent mining company specializing in zinc, copper, and lead productio

Source: Two Blokes Trading

CRISPR Therapeutics AG (NASDAQ:CRSP) Overview: A Leader in Gene Editing

Posted Feb 18 by John Deo

The consensus price target for CRISPR Therapeutics AG (NASDAQ:CRSP) has been adjusted from $72.75 to $65, ref

Source: Two Blokes Trading

Analog Devices, Inc. (NASDAQ:ADI) Sees Positive Analyst Sentiment Amid Industry Challenges

Posted Feb 18 by John Deo

ADI's consensus price target has been on an upward trend, indicating growing analyst optimism about the compa

Source: Two Blokes Trading

Matador Resources Company (NYSE:MTDR) Sees Positive Shift in Analyst Consensus

Posted Feb 18 by John Deo

Matador Resources Company's (NYSE:MTDR) consensus price target has risen from $77.87 to $84 over the past yea

Source: Two Blokes Trading